Prof Declan Murphy
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
790 Scholarly works
9 Projects
HIGHLIGHTS
2026
Journal article
Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials
DOI: 10.1016/S1470-2045(26)00170-12026
Journal article
Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study
DOI: 10.1016/S1470-2045(26)00091-42026
Research grants (ARC, NHMRC, MRFF)
Unraveling Metastasis-Specific Immune Niches to Transform Cancer Treatment
2019
Research Grant
Up-Front Psma Alliance: Using Theranostics Early to Eradicate Prostate Cancer and Developing Novel Startegies for Psma-Negative Disease
2018
Journal article
Cold kit for prostate-Specific membrane antigen (PSMA) PET imaging: Phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
DOI: 10.2967/jnumed.117.1995542017
Conference Proceedings
Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA
DOI: 10.1093/annonc/mdx370.0022017
Research Grant
Biofocussed Prostate Cancer Radiotherapy (Birt): A Personalised Approach to Delivering the Right Dose to the Right Place
RECENT SCHOLARLY WORKS
2026
Journal article
IP73-13 REAL-WORLD DAROLUTAMIDE SAFETY AND EFFECTIVENESS IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) WITH COMORBIDITIES AND CONCOMITANT MEDICATIONS: POST HOC ANALYSES AT DAROL INTERIM ANALYSIS 4 (IA4)
DOI: 10.1097/01.ju.0001191728.67566.6d.132026
Journal article
Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial
DOI: 10.1016/j.euo.2024.11.0062026
Journal article
A0782 PSA thresholds for salvage therapy after radical prostatectomy in PSMA-negative patients: Toward a redefinition of early salvage radiation therapy
DOI: 10.1016/s0302-2838(26)00828-62026
Journal article
Real-world darolutamide safety and effectiveness in nonmetastatic castration-resistant prostate cancer (nmCRPC) by lipid-modifying agent use: Post hoc analyses of DAROL interim analysis 4 (IA4).
DOI: 10.1200/jco.2026.44.7_suppl.992026
Journal article
P0624 An international delphi consensus on the use of ex-vivo fluorescent confocal microscopy for intraoperative margin assessment during robot-assisted radical prostatectomy
DOI: 10.1016/s0302-2838(26)01505-82026
Journal article
A 24-Year Analysis of Percutaneous Renal Biopsy Trends in Australia
DOI: 10.3390/medsci140100192026
Journal article
A0342 5-year outcomes of stereotactic radiotherapy for primary renal cell carcinoma from the pooled analysis of the FASTRACK trials
DOI: 10.1016/s0302-2838(26)00398-22026
Journal article
Utilization of prostate-specific membrane antigen positron emission tomography in Australia following government subsidization: Trends in primary staging and biochemical recurrence
DOI: 10.1016/j.prnil.2025.09.006